Hepatocellular carcinoma: development and early detection.
Our eventual aim is to predict, using non-invasive imaging techniques, the biological behaviour of individual cirrhotic nodules. We are some distance away from this, so our current objective is to define imaging features which predict the histologic findings. This short review summarises the current capabilities and limitations of non-invasive imaging in detecting small hepatocellular carcinomas (HCCs) in cirrhosis. Extracellular contrast media used with ultrasound (US), computed tomography (CT) or magnetic resonance imaging (MRI) can characterise nodules according to the predominance of arterial or portal inflow, and most HCCs will be recognised by their arterial hypervascularity. Adding intracellular (liver-specific) MRI contrast agents provides a significant improvement in early detection and in specificity for HCC. Nodules can be classified on dual contrast MRI as clearly malignant, clearly benign, or borderline (needing careful surveillance). Future imaging research needs to establish the histology of small hypervascular nodules, the evolution of hypervascular nodules and of dysplastic nodules, and to seek imaging features which predict microvascular invasion. Currently, cirrhotic patients with either suspicious nodules on screening US or rising AFP should have cross-sectional imaging with multi-phase CT or preferably MRI. Dual-contrast MRI with liver-specific agents should be used to improve diagnostic specificity for small lesions. Borderline nodules should be followed at agreed intervals using the same imaging technique each time. Pre-operative staging in surgical candidates should include CT of thorax, abdomen and pelvis and bone scintigraphy.
St James's University Hospital, Leeds LS9 7TF, UK. 106030.3217@compuserve.com
Philip
P
Robinson
D006528:Carcinoma, Hepatocellular / Q000098:blood supply / Q000175:diagnosis* / Q000209:etiology / Q000473:pathology; D042241:Early Diagnosis; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications / Q000473:pathology / Q000503:physiopathology; D008113:Liver Neoplasms / Q000098:blood supply / Q000175:diagnosis* / Q000209:etiology / Q000473:pathology; D008279:Magnetic Resonance Imaging; D009367:Neoplasm Staging; D014057:Tomography, X-Ray Computed